Cargando…

PET/CT in the Staging of the Non-Small-Cell Lung Cancer

Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT), combining a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chao, Fangfang, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346692/ https://www.ncbi.nlm.nih.gov/pubmed/22577296 http://dx.doi.org/10.1155/2012/783739

Ejemplares similares

PET/CT for staging and monitoring non small cell lung cancer
por: Rankin, Sheila
Publicado: (2008)

A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer
por: Xie, Yunming, et al.
Publicado: (2021)

Staging of lung cancer CT and PET
por: McLoud, Theresa C
Publicado: (2014)

Invasive mediastinal staging by endosonography or video-assisted mediastinoscopy in PET-CT clinical N1 non-small cell lung cancer
por: Decaluwé, Herbert, et al.
Publicado: (2020)

Advantages of Combined PET-CT in Mediastinal Staging in Patients with Non-small Cell Lung Carcinoma
por: Beslic, Nermina, et al.
Publicado: (2016)

The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre
por: Johnson, Anne, et al.
Publicado: (2021)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
por: Hannequin, Pascal, et al.
Publicado: (2022)

FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer
por: ZHENG, YUANDA, et al.
Publicado: (2014)

FDG PET/CT and Mediastinal Nodal Metastasis Detection in Stage T1 Non-Small Cell Lung Cancer: Prognostic Implications
por: Shin, Kyung Min, et al.
Publicado: (2008)

Efficacy of Camrelizumab in Advanced Non-Small-Cell Lung Cancer and Prognostic Analysis of Different PET/CT Features
por: Zou, Jinhai, et al.
Publicado: (2022)

Predictive Value of (18)F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer
por: Ko, Kai-Hsiung, et al.
Publicado: (2015)

The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer
por: Jiménez-Bonilla, Julio Francisco, et al.
Publicado: (2016)

(18)F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer
por: Wang, Jie, et al.
Publicado: (2023)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Multidisciplinary Postoperative Validation of (18)F-FDG PET/CT Scan in Nodal Staging of Resected Non-Small Cell Lung Cancer
por: Bedetti, Benedetta, et al.
Publicado: (2022)

Clinical usefulness of (18)F-FDG PET/CT for the detection of distant metastases in patients with non-small cell lung cancer at initial staging: a meta-analysis
por: Yu, Binbin, et al.
Publicado: (2018)

PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort
por: Brose, Alexander, et al.
Publicado: (2023)

The maximum standardized FDG uptake on PET-CT in patients with non-small cell lung cancer
por: Özgül, Mehmet Akif, et al.
Publicado: (2013)

Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
por: Hockmann, Jan, et al.
Publicado: (2023)

Deep Learning to Predict the Cell Proliferation and Prognosis of Non-Small Cell Lung Cancer Based on FDG-PET/CT Images
por: Hu, Dehua, et al.
Publicado: (2023)

Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?
por: Ordu, Cetin, et al.
Publicado: (2014)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
por: Combes, Alexander D., et al.
Publicado: (2022)

Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin’s Lymphoma
por: Fueger, Barbara J., et al.
Publicado: (2009)

Clinical Significance of Quantitative FDG PET/CT Parameters in Non-Small Cell Lung Cancer Patients
por: Behgam Shadmehr, Mohammad, et al.
Publicado: (2020)

Potentials of Non-Invasive (18)F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer
por: Liao, Xuhe, et al.
Publicado: (2022)

The lung cancers: staging and response, CT, (18)F-FDG PET/CT, MRI, DWI: review and new perspectives
por: Owens, Cara, et al.
Publicado: (2023)

Respiration-Averaged CT for Attenuation Correction of PET Images – Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients
por: Cheng, Nai-Ming, et al.
Publicado: (2016)

The correlation of expression of VEGF and EGFR with SUV of (18)FDG-PET-CT in non-small cell lung cancer
por: Liu, Xiguang, et al.
Publicado: (2014)

Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
por: Liu, Yi, et al.
Publicado: (2019)

Investigating the influence of long-axial versus short-axial field of view PET/CT on stage migration in lymphoma and non-small cell lung cancer
por: Alberts, Ian, et al.
Publicado: (2023)

Utility of PET-CT in non-small cell lung cancer clinical stage IB-IIA according to AJCC 8th edition staging system: an alternative to invasive mediastinal staging?
por: Buero, Agustin, et al.
Publicado: (2021)

Clinical evaluation of contrast-enhanced CT combined with PET/CT in diagnosis of mediastinal lymph node metastasis of non-small-cell lung cancer
por: Li, Xiaodong, et al.
Publicado: (2022)

Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis
por: Park, Yong-Jin, et al.
Publicado: (2023)

Impact of PET - CT motion correction in minimizing the gross tumor volume in non-small cell lung cancer
por: Masoomi, Michael A, et al.
Publicado: (2013)

(18)F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer
por: Li, Li, et al.
Publicado: (2020)

Impact of staging with (18)F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors
por: Eschmann, S. M., et al.
Publicado: (2006)

Prognostic value of (18)F‐fluoroazomycin arabinoside PET/CT in patients with advanced non‐small‐cell lung cancer
por: Saga, Tsuneo, et al.
Publicado: (2015)

The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging
por: Yousefi-Koma, Abbas, et al.
Publicado: (2013)

Clinical significance of PET/CT uptake for peripheral clinical N0 non‐small cell lung cancer
por: Wang, Shuai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qef6g582rktmi4o16s14tim11i